Quercus alba pollen

Identification

Summary

Quercus alba pollen is an extract from Quercus alba pollen used in allergy testing.

Generic Name
Quercus alba pollen
DrugBank Accession Number
DB10376
Background

Quercus alba pollen, or oak white pollen, is a non-standardized allergen extract used for the diagnosis and treatment of allergic disease to grass pollen. It can be subcutaneously administered to initiate an immune response in case of an allergic reaction. Diagnostic allergenic extracts are primarily indicated for establishing clinical relevance of specific allergens to which the patient has been exposed and the degree of sensitivity the patient has toward that allergen.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Center-AL - Quercus Alba PollenInjection, suspension10000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1975-01-15Not applicableUS flag
Quercus Alba PollenInjection, solution40000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag
Quercus Alba PollenInjection, solution0.05 g/1mLPercutaneousALK-Abello, Inc.1965-01-012021-11-30US flag
Quercus Alba PollenInjection, solution0.05 g/1mLSubcutaneousALK-Abello, Inc.1965-01-012021-11-30US flag
Quercus Alba PollenInjection, solution20000 [PNU]/1mLSubcutaneousALK-Abello, Inc.1965-01-012021-11-30US flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
2-oak Mix, Red/white PollenQuercus alba pollen (0.5 g/20mL) + Quercus rubra pollen (0.5 g/20mL)Injection, solutionPercutaneous; SubcutaneousAllergy Laboratories, Inc.1967-12-07Not applicableUS flag
5-oak Mix, Blackjack/bur/post/red/white PollenQuercus alba pollen (0.20 g/20mL) + Quercus macrocarpa pollen (0.20 g/20mL) + Quercus nigra pollen (0.20 g/20mL) + Quercus rubra pollen (0.20 g/20mL) + Quercus stellata pollen (0.20 g/20mL)Injection, solutionPercutaneous; SubcutaneousAllergy Laboratories, Inc.1967-12-07Not applicableUS flag
9 Tree MixQuercus alba pollen (0.05 g/1mL) + Acer saccharum pollen (0.05 g/1mL) + Alnus rhombifolia pollen (0.05 g/1mL) + Betula lenta pollen (0.05 g/1mL) + Carya ovata pollen (0.05 g/1mL) + Fraxinus americana pollen (0.05 g/1mL) + Platanus occidentalis pollen (0.05 g/1mL) + Populus alba pollen (0.05 g/1mL) + Ulmus crassifolia pollen (0.05 g/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1998-02-23Not applicableUS flag
9 Tree MixQuercus alba pollen (10000 [PNU]/1mL) + Acer saccharum pollen (10000 [PNU]/1mL) + Alnus rhombifolia pollen (10000 [PNU]/1mL) + Betula lenta pollen (10000 [PNU]/1mL) + Carya ovata pollen (10000 [PNU]/1mL) + Fraxinus americana pollen (10000 [PNU]/1mL) + Platanus occidentalis pollen (10000 [PNU]/1mL) + Populus alba pollen (10000 [PNU]/1mL) + Ulmus americana pollen (10000 [PNU]/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1975-01-15Not applicableUS flag
9 Tree MixQuercus alba pollen (0.1 g/1mL) + Acer saccharinum pollen (0.1 g/1mL) + Alnus rhombifolia pollen (0.1 g/1mL) + Betula lenta whole (0.1 g/1mL) + Carya ovata pollen (0.1 g/1mL) + Fraxinus americana pollen (0.1 g/1mL) + Platanus occidentalis pollen (0.1 g/1mL) + Populus alba pollen (0.1 g/1mL) + Ulmus crassifolia pollen (0.1 g/1mL)Injection, solutionSubcutaneousALK-Abello, Inc.1965-01-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Z4Y9ZSV4KK
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910552
RxNav
852294

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionPercutaneous; Subcutaneous
Injection, solutionPercutaneous
Injection, solutionSubcutaneous
Injection, suspensionSubcutaneous10000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous
Injection, solutionIntradermal
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.001 g/1mL
Injection, solutionSubcutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.10 g/1mL
Injection, solutionSubcutaneous10000 [PNU]/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
Injection, solutionSubcutaneous50000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.050 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous20000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53